Cargando…
A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma
Glioblastomas (GBM) are aggressive tumors that lack effective treatments. Here, we show that the Rho family guanine nucleotide exchange factor Syx promotes GBM cell growth both in vitro and in orthotopic xenografts derived from patients with GBM. Growth defects upon Syx depletion are attributed to p...
Autores principales: | Lin, Wan-Hsin, Feathers, Ryan W., Cooper, Lisa M., Lewis-Tuffin, Laura J., Chen, Jiaxiang, Sarkaria, Jann N., Anastasiadis, Panos Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371349/ https://www.ncbi.nlm.nih.gov/pubmed/37427593 http://dx.doi.org/10.1172/jci.insight.157491 |
Ejemplares similares
-
Characterization and computational simulation of human Syx, a RhoGEF implicated in glioblastoma
por: Boyd, Ryan J., et al.
Publicado: (2022) -
VEGF and Angiopoietin-1 exert opposing effects on cell junctions by regulating the Rho GEF Syx
por: Ngok, Siu P., et al.
Publicado: (2012) -
The RhoA GEF Syx Is a Target of Rnd3 and Regulated via a Raf1-Like Ubiquitin-Related Domain
por: Goh, Liuh Ling, et al.
Publicado: (2010) -
VEGF-A/NRP1 stimulates GIPC1 and Syx complex formation to promote RhoA activation and proliferation in skin cancer cells
por: Yoshida, Ayumi, et al.
Publicado: (2015) -
Misregulated E-Cadherin Expression Associated with an Aggressive Brain Tumor Phenotype
por: Lewis-Tuffin, Laura J., et al.
Publicado: (2010)